Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 654 of 1,261

  1. US 9545452

    Biomineral and metal binding liposomes, their synthesis, and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  2. US 9539342

    Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  3. US 9540337

    Gamma-glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  4. US 9539301

    Melanotropin ligands for skin care

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  5. US 9539228

    Composition containing lysine as a nutritional supplement or treatment in the case of herpes

    Reiner Rittinghausen · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  6. US 9539220

    Methods for treating suicidal ideation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  7. US 9539330

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  8. US 9540415

    Inhibitors of the farnesoid X receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  9. US 9539234

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  10. US 9540641

    Cancer treatment

    Ionis Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  11. US 9540440

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  12. US 9540642

    Compositions and methods for controlling arthropod parasite and pest infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  13. US 9541545

    Fluorescent neutralization and adherence inhibition assays

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  14. US 9539231

    Method for treating triple-negative breast cancer using AMPI-109

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  15. US 9540395

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  16. US 9540643

    Organic compositions to treat HSF1-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  17. US 9540449

    Anti-PCSK9 antibodies with pH-dependent binding characteristics

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  18. US 9540427

    Peptide-based stat inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  19. US 9540380

    Imidazotriazinone compounds

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  20. US 9540334

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  21. US 9539341

    Methods and compositions for targeting adipose cells in mammals

    The Board of Regents of the University of Texas System · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  22. US 9540330

    Oligomer-containing hydantoin compounds

    Nektar Therapeutics · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  23. US 9539340

    Bladder cancer specific ligand peptides

    The Regents of the University of California · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  24. US 9539337

    Compositions comprising two different populations of polymer-active agent conjugates

    Nektar Therapeutics · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.